🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cell...
Status
Completed
Location
Herbert Irving Comprehensive Cancer Center
Start Date
1996-05
Trial ID
NCT00008203
RATIONALE: - Relapsed or refractory Neuroblastoma (NBL) carries a very poor...
Status
Withdrawn
Location
Children's Memorial Hospital
Start Date
2008-09
Trial ID
NCT00874315
RATIONALE: Giving chemotherapy drugs, such as fludarabine and cyclophospham...
Status
Completed
Location
Masonic Cancer Center at University of Minnesota
Start Date
2005-07-28
Trial ID
NCT00309842
RATIONALE: Giving low doses of chemotherapy, such as fludarabine, and radia...
Status
Completed
Location
Veterans Affairs Medical Center - Seattle
Start Date
2005-04
Trial ID
NCT00119340
This protocol is an open label, single arm, non-randomized, phase I / II cl...
Status
Completed
Location
University of Michigan Comprehensive Cancer Center
Start Date
2015-01
Trial ID
NCT02328755
Treatments Being Tested
This study will assess safety and efficacy of AEB071 combined with everolim...
Status
Completed
Location
Argentina
Start Date
2007-07
Trial ID
NCT00504543
The purpose of this study was to compare the safety and efficacy of three i...
Status
Completed
Location
Novartis
Start Date
2005-10
Trial ID
NCT00251004
Treatments Being Tested
This study is designed to test the ability to achieve donor hematopoietic e...
Status
Completed
Location
Masonic Cancer Center, University of Minnesota
Start Date
2012-07-11
Trial ID
NCT01626092
RATIONALE: Giving chemotherapy, such as fludarabine phosphate, busulfan, an...
Status
Completed
Location
HealthOne Presbyterian St. Lukes Medical Center
Start Date
2006-01
Trial ID
NCT00322101
Treatments Being Tested
The main purpose of this trial is to assess the safety and feasibility of t...
Status
Completed
Location
Hospital de Jerez de la Frontera.
Start Date
2010-06
Trial ID
NCT01222039